Try our Advanced Search for more refined results
Securities
-
January 17, 2026
Up Next At High Court: Fed Firing & Gun 'Vampire Rules'
The Supreme Court will begin a short argument week Tuesday, during which the justices will consider President Donald Trump's authority to fire a Democratic Federal Reserve governor over allegations of mortgage fraud, as well as the ability for states to presumptively bar gun owners from carrying firearms onto private property open to the public unless the property owner explicitly allows it.
-
January 16, 2026
SEC Fines Adviser Over Black Rifle Coffee SPAC Deal Conflict
Engaged Capital LLC was fined $200,000 by the U.S. Securities and Exchange Commission and agreed to a censure Friday over allegations the investment adviser failed to disclose conflicts of interest related to a special purpose acquisition company merger with Black Rifle Coffee Co. in 2022.
-
January 16, 2026
OCC's Gould Takes Aim At Resolution Planning 'Industry'
A top federal regulator called Friday for a sweeping rethink of rules intended to ensure big, complex banks can be safely wound down in a crisis, including potentially ending requirements to file so-called living wills with the Federal Deposit Insurance Corp.
-
January 16, 2026
Stock Buyback Ban Could Shrink Defense Industrial Base
The Trump administration's move to bar defense contractors from buying back their stock or paying shareholder dividends if they are underperforming on their contracts could make companies reconsider working with the U.S. government and counteract the administration's stated goals.
-
January 16, 2026
SEC Secures $39M Orders Wrapping Fla. Investor Fraud Suit
The U.S. Securities and Exchange Commission has gotten final judgments totaling nearly $39 million to wrap up claims that a Florida hedge fund manager, associated entities and their owner defrauded would-be investors by concealing self-dealing and misappropriation.
-
January 16, 2026
SEC Fines Biopharma Co. Execs Over Hidden FDA Findings
Former executives of Spero Therapeutics will pay over $187,000 to settle the U.S. Securities and Exchange Commission's claims they downplayed the likelihood that the U.S. Food and Drug Administration would reject the biopharmaceutical company's new drug application in 2022, the commission said on Friday.
-
January 16, 2026
SEC Fines 'Cash Flow King' Podcaster $3M For Ponzi Scheme
A podcast host dubbed the "Cash Flow King" will pay $3.3 million to settle claims that he ran a multiyear Ponzi scheme that cheated investors out of $11 million through bogus real estate investments, the U.S. Securities and Exchange Commission announced Friday.
-
January 16, 2026
Lifecore Investors Ink $3.8M Deal In Accounting Controls Suit
Biotech company Lifecore Biomedical Inc. has reached a $3.8 million deal with its investors to end their claims the company had weak controls over its financial reporting, impairing its ability to remain compliant with Nasdaq listing requirements and causing share declines.
-
January 16, 2026
6th Circ. Revives Biomed Co. Investor's Suit Over Stock Sale
The Sixth Circuit has ruled that a man who sold his stock in a biomedical research company just before being told the company planned to pursue private equity financing can bring his breach of contract and fiduciary duty claims, reversing a lower court's ruling granting summary judgment to the biomedical company.
-
January 16, 2026
$29M Deal In Boeing Supplier Fraud Suit Gets Final OK
A New York federal judge on Friday approved a $29 million deal to close out a suit alleging that Spirit AeroSystems Holdings Inc. misled investors by failing to disclose pervasive quality problems and a documented history of supplying its chief customer, The Boeing Co., with defective plane parts.
-
January 16, 2026
SIFMA Presses SEC To Reverse Nasdaq Fee Hike
The Securities Industry and Financial Markets Association is urging the U.S. Securities and Exchange Commission to force Nasdaq and other exchanges to stop collecting new fees that the organization argues were allowed to go live with little detail as to why they were necessary or how they comply with the law and past SEC guidance.
-
January 16, 2026
Acadia Investors Get Initial OK For $179M Settlement
Acadia Healthcare Co. Inc. investors have received the first OK from a Tennessee federal judge for a $179 million settlement in a class action alleging the company misled them about the strength of its U.K. operations.
-
January 16, 2026
Pomerantz To Lead Biohaven Investors' FDA Approval Suit
Pomerantz LLP will lead a proposed class of investors accusing biopharmaceutical company Biohaven Ltd. of overstating the odds that two of its product candidates would receive regulatory approval, a Connecticut judge said Friday.
-
January 16, 2026
Judge Yanks $41M Atty Fee Award In SPAC Merger Suit
A Texas federal judge has rescinded an attorney fee award of over $41 million to Robbins Geller Rudman & Dowd LLP, Labaton Keller Sucharow LLP and Entwistle & Cappucci LLP after the firms became engaged in a dispute over the amount of work done and the allocation of fees, among other things.
-
January 16, 2026
7th Circ. Won't Revive Investment Cos.' VIX-Fix Claims
The Seventh Circuit on Thursday affirmed the dismissal of two investment companies' volatility index manipulation claims against Barclays, Morgan & Stanley Co. and other financial institutions, agreeing with a lower court that one lacked standing and the other missed a statutory deadline.
-
January 16, 2026
High Court Takes Up Intel Workers' Bid To Revive 401(k) Suit
The U.S. Supreme Court agreed Friday to hear Intel workers' challenge to a Ninth Circuit decision backing an end to their proposed class action alleging 401(k) mismanagement, a case that gives the justices a chance to clarify the pleading standards for retirement fund underperformance.
-
January 16, 2026
Insurer Says Other Carrier Owes $23M For Old Policy Claims
Sparta Insurance Co. said the former parent of an insurer it acquired reneged on its contractual obligations to handle and pay claims under policies issued before the acquisition, telling a Massachusetts federal court that it is owed more than $23 million in settlement payments, attorney fees and other costs.
-
January 15, 2026
NCAA Urges Feds, States To Rein In College Sports Wagers
The NCAA has urged a federal regulator to suspend prediction market trades based on college sports until appropriate safeguards are in place and called on state gambling commissions to restrict certain types of wagers, saying it knows they are being manipulated.
-
January 15, 2026
SEC Says Healthcare Exec Misspent $10.6M In Investor Funds
The U.S. Securities and Exchange Commission on Thursday accused a healthcare company CEO of misappropriating over $10 million from investors by falsely claiming the funds would be used to develop cancer screening and treatment technology when in fact they were spent on credit card debt, luxury vehicles and strip club visits.
-
January 15, 2026
Getty Loses 2nd Circ. Bid Over $88M Stock Sale Breach Order
A divided Second Circuit on Thursday upheld a ruling requiring Getty Images to pay out nearly $88 million to investors who said they were blocked from purchasing shares in the company once it became public, finding Getty breached a contract promising the investors those shares.
-
January 15, 2026
Musk Slams SEC's 'Premature' Bid For Twitter Buy-Up Win
The U.S. Securities and Exchange Commission shouldn't be handed an early win on its claims Elon Musk didn't make timely disclosures of his stake in Twitter when the regulator hasn't yet produced discovery in the matter, the tech billionaire has argued.
-
January 15, 2026
Dechert Adds Ex-NYC Deputy Mayor To Co-Lead Trial Practice
Dechert LLP announced Thursday that it has hired veteran trial lawyer Randy Mastro, who previously served as former New York City Mayor Eric Adams' first deputy, as a partner and co-chair of the firm's securities and complex litigation practice.
-
January 15, 2026
Ex-CEO Of COVID Vax Maker Accused Of Insider Trading
New York Attorney General Letitia James on Thursday sued the former CEO of healthcare contractor Emergent BioSolutions Inc., alleging insider trading amid troubles manufacturing a COVID-19 vaccine, while signing a $900,000 settlement with the company over its approval of an executive trading plan.
-
January 15, 2026
Dems Push SEC To Pursue Crypto Case Against Justin Sun
Three House Democrats on Thursday pressed the U.S. Securities and Exchange Commission to reinvigorate its paused enforcement case against Tron founder Justin Sun and address their concerns that the agency's wave of crypto case dismissals coincided with considerable industry donations to President Donald Trump.
-
January 15, 2026
Chancery Tosses Vividion IP Suit Over $2B Bayer Deal
The Delaware Chancery Court on Thursday dismissed a biotech investor's suit accusing the co-founder of Vividion Therapeutics Inc. and others of diverting valuable intellectual property ahead of the company's $2 billion sale to Bayer Corp., finding the alleged misconduct could not have affected the merger price or process under Delaware law.
Expert Analysis
-
Assessing The SEC's Changing Approach To NFT Regulation
Early U.S. Securities and Exchange Commission actions on nonfungible tokens pushed for broad regulation, but subsequent court decisions — including a recent California federal court ruling in Adonis Real v. Yuga Labs — and SEC commissioners' statements have narrowed the regulatory focus toward a more fact-specific approach, say attorneys at Wilson Elser.
-
Where Crypto Mixing Enforcement Is Headed From Here
Recent developments involving crypto mixers, particularly the Tornado Cash verdict, demonstrate that the Justice Department's shift away from regulation by prosecution does not mean total immunity, rather reflecting an approach that prioritizes both innovation and accountability, says David Tarras at Tarras Defense.
-
Why Foreign Cos. Should Prep For Increased SEC Oversight
With the recent trading suspensions of 10 foreign-based issuers listed on the Nasdaq, an enforcement action against a U.K. security-based swap dealer and the announcement of a cross-border task force, it's clear that the U.S. Securities and Exchange Commission will expand oversight on foreign companies participating in the U.S. capital markets, says Tejal Shah at Cooley.
-
What Narrower FinCEN Reporting Spells For Industry
As compliance costs soar, the potential slimming down of the Financial Crimes Enforcement Network's anti-money laundering and countering the financing of terrorism regime is welcome news for banks, and would allow a shift in resources to ever-evolving cybercrime threats, say attorneys at Quarles & Brady.
-
Revisiting Jury Trial Right May Upend State Regulatory Power
Justice Neil Gorsuch’s recent use of a denial of certiorari to call for the U.S. Supreme Court to revisit whether the Seventh Amendment jury trial right extends to states, building off last year's Jarkesy ruling, could foretell a profound change in state regulators' ability to enforce penalties against regulated companies, say attorneys at Sidley.
-
How Nasdaq, SEC Proposals May Transform Listing Standards
Both Nasdaq and the U.S. Securities and Exchange Commission have increasingly focused their recent regulatory efforts on small and foreign issuers, particularly those from China, reflecting an intention to strengthen the overall quality of companies accessing U.S. markets, but also potentially introducing a chilling effect on certain issuers, say attorneys at Norton Rose.
-
Series
Building With Lego Makes Me A Better Lawyer
Building with Lego has taught me to follow directions and adapt to unexpected challenges, and in pairing discipline with imagination, allows me to stay grounded while finding new ways to make complex deals come together, says Paul Levin at Venable.
-
How Banks Can Safely Handle Payments For Gambling Biz
As the betting market continues to expand, it's crucial for banks and fintechs to track historical developments in wagering and ongoing prediction markets litigation that can factor into a risk analysis for payment processing with respect to gambling operators, says Laura D'Angelo at Jones Walker.
-
SEC Focused On Fraud As Actions Markedly Declined In 2025
The U.S. Securities and Exchange Commission's enforcement activity in its fiscal year 2025 was its lowest in 10 years, reflecting not only a significant decline in the commission's workforce, but also Chairman Paul Atkins' stated focus on fraud and individual wrongdoing and a new approach to crypto regulation, say attorneys at Covington.
-
Series
Law School's Missed Lessons: Networking 101
Cultivating a network isn't part of the law school curriculum, but learning the soft skills needed to do so may be the key to establishing a solid professional reputation, nurturing client relationships and building business, says Sharon Crane at Practising Law Institute.
-
Defeating Estoppel-Based Claims In Legal Malpractice Actions
State supreme court cases from recent years have addressed whether positions taken by attorneys in an underlying lawsuit can be used against them in a subsequent legal malpractice action, providing a foundation to defeat ex-clients’ estoppel claims, says Christopher Blazejewski at Sherin and Lodgen.
-
How Cos. Can Prep For Tightened Calif. Data Breach Notices
Amid California's recent enactment of S.B. 446, which significantly amends the state's data breach notification laws, companies should review and update their incident response plans by establishing processes to document and support any delayed notification, and ensure the notifications' accuracy, say Mark Krotoski and Alexandria Marx at Pillsbury.
-
Digital Asset Treasury Trend Signals Wider Crypto Embrace
While digital asset treasuries are not new for U.S. public companies, the recent velocity of capital deployment in such investments has been notable, signaling a transformation in corporate treasury management that blurs the lines between traditional finance and the broader crypto ecosystem, say attorneys at DLA Piper.
-
Series
The Biz Court Digest: How It Works In Massachusetts
Since its founding in 2000, the Massachusetts Business Litigation Session's expertise, procedural flexibility and litigant-friendly case management practices have contributed to the development of a robust body of commercial jurisprudence, say James Donnelly at Mirick O’Connell, Felicia Ellsworth at WilmerHale and Lisa Wood at Foley Hoag.
-
How The SEC May Overhaul Its Order Protection Rule
Attorneys at Skadden trace the evolution of the controversial Rule 611 of Regulation National Market System, examine the current debate surrounding its effectiveness, and consider how the U.S. Securities and Exchange Commission's emerging Project Crypto initiative could reshape Regulation NMS for a tokenized, on-chain market environment.